Return to Special Authority drug list
Generic name |
tofacitinib |
|
Strength & form |
5 mg tablet |
Special Authority criteria |
Approval period |
---|---|
InitialFor the treatment of adult patients (≥ 18 years of age) with moderate to severe ankylosing spondylitis, when ALL of the following criteria are met:
AND
AND
For predominantly axial disease
AND
AND
For predominantly peripheral disease
|
1 year |
RenewalFor the continued treatment of adult patients with moderate to severe ankylosing spondylitis when ALL of the following criteria are met:
AND
|
1 year, 3 years, or indefinite6 |